JPY 2999.0
(-0.86%)
Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
---|---|---|---|---|---|---|
Revenue | 18.6 Billion | 15.77 Billion | 17.15 Billion | 17.55 Billion | 18.63 Billion | 19.08 Billion |
Cost of Revenue | 15.2 Billion | 12.83 Billion | 14.56 Billion | 14.77 Billion | 15.63 Billion | 16.05 Billion |
Gross Profit | 3.4 Billion | 2.94 Billion | 2.58 Billion | 2.78 Billion | 3 Billion | 3.02 Billion |
Operating Expenses | 2.19 Billion | 2.12 Billion | 2.05 Billion | 1.99 Billion | 1.99 Billion | 1.88 Billion |
Selling, General and Administrative Expenses | 513.16 Million | 387.52 Million | 449.07 Million | 502.03 Million | 539.03 Million | 546.62 Million |
Research and Development Expenses | 209.57 Million | 449.73 Million | 338.33 Million | 169.1 Million | 79.01 Million | 50.17 Million |
Other Expenses | 1.48 Billion | 204.72 Million | 192.6 Million | 130.71 Million | 108.61 Million | 109.72 Million |
Cost and Expenses | 17.4 Billion | 14.96 Billion | 16.62 Billion | 16.77 Billion | 17.62 Billion | 17.93 Billion |
Operating Income | 1.2 Billion | 816.81 Million | 537.67 Million | 788.11 Million | 1.01 Billion | 1.14 Billion |
Interest Expense | 5.17 Million | 4.39 Million | 3.94 Million | 3.91 Million | 3.65 Million | 3.52 Million |
Income Tax Expense | 457.37 Million | 317.96 Million | 252.33 Million | 305.54 Million | 339.66 Million | 418.02 Million |
Earnings before Tax | 1.47 Billion | 1.12 Billion | 808.85 Million | 979.28 Million | 1.08 Billion | 1.32 Billion |
Net Income | 1.02 Billion | 806.4 Million | 556.52 Million | 673.74 Million | 741.78 Million | 907.92 Million |
Earnings Per Share Basic | 288.54 | 225.81 | 155.84 | 188.20 | 204.49 | 249.87 |
Earnings Per Share Diluted | 288.54 | 225.81 | 155.84 | 188.20 | 204.49 | 249.87 |
Weighted Average Shares Outstanding | 3.53 Million | 3.57 Million | 3.57 Million | 3.57 Million | 3.62 Million | 3.63 Million |
Weighted Average Shares Outstanding (Diluted) | 3.53 Million | 3.57 Million | 3.57 Million | 3.57 Million | 3.62 Million | 3.63 Million |
Gross Margin | 0.18 | 0.19 | 0.15 | 0.16 | 0.16 | 0.16 |
EBIT Margin | 0.09 | 0.09 | 0.06 | 0.07 | 0.08 | 0.09 |
Profit Margin | 0.05 | 0.05 | 0.03 | 0.04 | 0.04 | 0.05 |
EBITDA | 1.68 Billion | 1.36 Billion | 1.03 Billion | 1.2 Billion | 1.34 Billion | 1.63 Billion |
Earnings Before Tax Margin | 0.06 | 0.05 | 0.03 | 0.04 | 0.05 | 0.06 |
Breakdown | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 | 2023 Q1 |
---|---|---|---|---|---|---|
Revenue | 4.85 Billion | 5.16 Billion | 18.6 Billion | 4.49 Billion | 4.79 Billion | 4.16 Billion |
Cost of Revenue | 4.06 Billion | 4.41 Billion | 15.21 Billion | 3.63 Billion | 3.87 Billion | 3.28 Billion |
Gross Profit | 788 Million | 745.38 Million | 3.39 Billion | 859.19 Million | 911.31 Million | 879.53 Million |
Operating Expenses | 661 Million | 501.45 Million | 2.19 Billion | 539.13 Million | 548.73 Million | 502.52 Million |
Selling, General and Administrative Expenses | 660 Million | 414.81 Million | - | 488.79 Million | 511.79 Million | 466.86 Million |
Research and Development Expenses | - | 86.63 Million | - | 50.33 Million | 36.94 Million | 35.65 Million |
Other Expenses | 1 Million | 36.77 Million | -70.36 Million | 31.01 Million | 56.29 Million | 27.7 Million |
Cost and Expenses | 4.72 Billion | 4.91 Billion | 17.4 Billion | 4.17 Billion | 4.42 Billion | 3.78 Billion |
Operating Income | 127 Million | 243.93 Million | 1.2 Billion | 320.05 Million | 362.57 Million | 377.01 Million |
Interest Expense | 1.45 Million | 1.47 Million | 5.17 Million | 1.22 Million | 1.17 Million | 1.29 Million |
Income Tax Expense | 361 Million | 62.43 Million | 457.37 Million | 119.3 Million | 146.77 Million | 128.85 Million |
Earnings before Tax | 1.16 Billion | 201.93 Million | 1.47 Billion | 385.48 Million | 434.91 Million | 455.64 Million |
Net Income | 805 Million | 139.5 Million | 1.02 Billion | 266.17 Million | 288.14 Million | 326.79 Million |
Earnings Per Share Basic | 227.98 | 39.47 | - | 75.38 | 81.60 | 92.03 |
Earnings Per Share Diluted | 227.98 | 39.47 | - | 75.38 | 81.60 | 92.03 |
Weighted Average Shares Outstanding | 3.53 Million | 3.53 Million | 3.53 Million | 3.53 Million | 3.53 Million | 3.55 Million |
Weighted Average Shares Outstanding (Diluted) | 3.53 Million | 3.53 Million | 3.53 Million | 3.53 Million | 3.53 Million | 3.55 Million |
Gross Margin | 0.16 | 0.14 | 0.18 | 0.19 | 0.19 | 0.21 |
EBIT Margin | 0.04 | 0.06 | - | 0.08 | 0.09 | 0.11 |
Profit Margin | 0.17 | 0.03 | 0.05 | 0.06 | 0.06 | 0.08 |
EBITDA | 177.25 Million | 301.56 Million | - | 372.81 Million | 436.08 Million | 456.94 Million |
Earnings Before Tax Margin | 0.03 | 0.05 | 0.06 | 0.07 | 0.08 | 0.09 |
PTAIY
000681
MTAM
LODHA
CME
AMBUJACEM